Cannabinoides
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (30)
2024
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783
2023
-
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
Nature Communications, Vol. 14, Núm. 1
-
Mammalian CDC14 phosphatases control exit from stemness in pluripotent cells
EMBO Journal, Vol. 42, Núm. 1
-
Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43
Neuropharmacology, Vol. 240
-
The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice
Neurobiology of Disease, Vol. 184
2022
-
Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation
Journal of experimental & clinical cancer research : CR, Vol. 41, Núm. 1, pp. 285
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941
2020
-
Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor**
Chemistry - A European Journal, Vol. 26, Núm. 68, pp. 15839-15842
-
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease
eLife, Vol. 9
-
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
Scientific Reports, Vol. 10, Núm. 1
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
2018
-
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Biochemical Pharmacology, Vol. 157, pp. 67-84
-
Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 7, pp. 2385-2394
-
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum
Neuropsychopharmacology, Vol. 43, Núm. 5, pp. 964-977
2016
-
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
Pharmacology Research and Perspectives, Vol. 4, Núm. 2
-
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis
Journal of Medicinal Chemistry, Vol. 59, Núm. 14, pp. 6753-6771
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222